ATE311101T1 - Abbildung von transgenen markern - Google Patents

Abbildung von transgenen markern

Info

Publication number
ATE311101T1
ATE311101T1 AT02752606T AT02752606T ATE311101T1 AT E311101 T1 ATE311101 T1 AT E311101T1 AT 02752606 T AT02752606 T AT 02752606T AT 02752606 T AT02752606 T AT 02752606T AT E311101 T1 ATE311101 T1 AT E311101T1
Authority
AT
Austria
Prior art keywords
imaging marker
radiolabeled
cells
illustration
animals
Prior art date
Application number
AT02752606T
Other languages
English (en)
Inventor
Jeffrey Paul Northrop
Joshua Morris Star-Lack
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of ATE311101T1 publication Critical patent/ATE311101T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0004Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/44Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00Modified animals
    • A01K2207/15Humanized animals
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/10Mammal
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/03Animal model, e.g. for test or diseases
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/03Animal model, e.g. for test or diseases
    • A01K2267/0393Animal model comprising a reporter system for screening tests
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/60Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622Single chain antibody (scFv)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Optics & Photonics (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Plant Pathology (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • User Interface Of Digital Computer (AREA)
  • Walking Sticks, Umbrellas, And Fans (AREA)
AT02752606T 2001-07-30 2002-07-29 Abbildung von transgenen markern ATE311101T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30891901P 2001-07-30 2001-07-30
PCT/US2002/023962 WO2003011020A1 (en) 2001-07-30 2002-07-29 Imaging marker transgenes

Publications (1)

Publication Number Publication Date
ATE311101T1 true ATE311101T1 (de) 2005-12-15

Family

ID=23195922

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02752606T ATE311101T1 (de) 2001-07-30 2002-07-29 Abbildung von transgenen markern

Country Status (6)

Country Link
US (1) US20030033616A1 (de)
EP (1) EP1418808B1 (de)
AT (1) ATE311101T1 (de)
DE (1) DE60207733T2 (de)
ES (1) ES2253548T3 (de)
WO (1) WO2003011020A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7693399B2 (en) * 2002-07-11 2010-04-06 Lg Electronics Inc. Method for providing program specific information recorded on high density disc medium
CA2580644A1 (en) * 2004-09-17 2006-03-30 University Of Utah Research Foundation Imaging reporters of transgene expression
AU2007234698B2 (en) * 2006-04-07 2013-08-01 The Board Of Regents Of The University Of Texas System Methods and compositions related to adenoassociated virus-phage particles
EP2027273B1 (de) 2006-05-17 2016-04-13 F. Hoffmann-La Roche AG Polypeptidproduzierende zellen
AU2009286956B2 (en) 2008-08-28 2012-12-06 Novartis Ag Cell surface display of polypeptide isoforms by stop codon readthrough
CN109790214B (zh) 2016-09-29 2022-09-06 豪夫迈·罗氏有限公司 用于选择产生多肽的细胞的改进方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2604092B1 (fr) * 1986-09-19 1990-04-13 Immunotech Sa Immunoreactifs destines a cibler les cellules animales pour leur visualisation ou leur destruction in vivo
WO1990000625A1 (en) * 1988-07-14 1990-01-25 Monoclonetics International, Inc. Pre-screening for depletion and enrichment of specific b-cells
US5185142A (en) * 1989-07-28 1993-02-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Antigen-specific composition and in vivo methods for detecting and localizing an antigenic site and for radiotherapy
US6017754A (en) * 1995-08-24 2000-01-25 Invitrogen Corporation System for isolating and identifying eukaryotic cells transfected with genes and vectors, host cells and methods thereof
WO2001057212A1 (en) * 2000-02-02 2001-08-09 Iconix Pharmaceuticals, Inc. Rapid, parallel identification of cell lines

Also Published As

Publication number Publication date
EP1418808A1 (de) 2004-05-19
WO2003011020A1 (en) 2003-02-13
US20030033616A1 (en) 2003-02-13
EP1418808B1 (de) 2005-11-30
DE60207733T2 (de) 2006-06-29
DE60207733D1 (de) 2006-01-05
EP1418808A4 (de) 2004-09-15
ES2253548T3 (es) 2006-06-01

Similar Documents

Publication Publication Date Title
Russell et al. Cattle domestication at Çatalhöyük revisited
ATE394658T1 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
PT1135467E (pt) Psca: antigénio de células estaminais da próstata e suas utilizações
IL142824A0 (en) Lipoic acid derivatives and their use in treatment of disease
EA200300464A1 (ru) ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ
DE69906992D1 (de) Zweite medizinische indikation einer partikelverabreichungsmethode
CY1105836T1 (el) 12, 13-τροποποιημενα παραγωγα εποθιλονης
DE602004019812D1 (de) Marker für neuromyelitis optica
Saini et al. Development of a simple enzyme immunoassay for blood haptoglobin concentration in cattle and its application in improving food safety
ATE356357T1 (de) Prostatakrebs-marker
Whetton Climate change impacts on the spatial extent of snow-cover in the Australian Alps
ATE311101T1 (de) Abbildung von transgenen markern
de Groene et al. Pigs in the Neolithic of the eastern Fertile Crescent: New evidence from Pre‐Pottery Neolithic Bestansur and Shimshara, Iraqi Kurdistan (7800–7100 BC)
ATE350662T1 (de) Markerproteine für prostatakrebs
BG101038A (bg) Супресия на растежа на туморни клетки посредствомсиндекан- 1 ектоучастък
DE60014064D1 (de) Einetenascin-c isoform als marker für neoplasmen
RU2008111144A (ru) Способы моделирования и ингибирования миграции раковых клеток
EA200500878A1 (ru) Кальцилитические соединения
WO2003063059A3 (en) Method for positively identifying livestock and use thereof in legal instruments relating thereto
Neveu Collado et al. Human and camelid paleodiets in El Bolson valley (NW Argentina): A stable isotope approach
ATE445842T1 (de) Nachweis spezifischer nitrierter marker
SE9803962D0 (sv) Nucleic acid encoding a nervous tissue sodium channel
EP1495056A4 (de) Antikörperdisulfidisomere, deren verwendung und verfahren zu deren analyse
EP1572931A4 (de) Verfahren und zusammensetzungen zur modulation und zum nachweis von wisp-aktivität
DK1747465T3 (da) Anvendelse af hidtil ukendte biomarkører til detektion af testikelcarcinom in situ og afledte cancere i humane prøver

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties